Search results
Intellia Therapeutics Inc [NTLA] Insider Activity: An Update for Investors – Knox Daily
Knox Daily· 19 hours agoIntellia Therapeutics Inc’s filing revealed that its EVP, General Counsel BASTA JAMES unloaded Company’s shares for reported $75778.0 on Mar 04 ’24. In ...
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics - Intellia Therapeutics...
Benzinga· 6 hours agoLoading... Loading... In the last three months, 4 analysts have published ratings on Intellia Therapeutics NTLA , offering a diverse range of perspectives ...
Is Intellia Therapeutics, Inc. (NASDAQ:NTLA) the Most Promising Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 1 day agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Intellia Up on Upbeat Long-Term Angioedema Study Data - Annovis Bio (NYSE:ANVS), ALX Oncology...
Benzinga· 6 hours agoIntellia Therapeutics' NTLA shares gained 10% on Jun 3 after the company reported encouraging...
Intellia Therapeutics shares retain buy rating on strong study results By Investing.com
Investing.com· 1 day agoOn Monday, TD Cowen maintained a Buy rating on shares of Intellia Therapeutics (NASDAQ:NTLA), a...
Why Intellia Therapeutics Shares Are Trading Higher Monday - Intellia Therapeutics (NASDAQ:NTLA)
Benzinga· 1 day agoIntellia Therapeutics, Inc. NTLA stock is moving higher Monday after the company announced long-term...
Intellia Therapeutics Inc (NTLA) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 5 days agoThe stock of Intellia Therapeutics Inc (NASDAQ: NTLA) has increased by 1.98 when compared to last closing price of 21.67. Despite this, the company has ...
Intellia’s CRISPR drug shows promise against hereditary angioedema in early-stage trial - Boston...
The Business Journals· 3 days agoOn Sunday, Intellia Therapeutics (Nasdaq: NTLA) said that its experimental gene-editing treatment...
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Motley Fool via Yahoo Finance· 15 hours agoJust be aware that this stock could be volatile in the meantime, depending on what breakthroughs (or...
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 5 days agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock